0
Defining and Quantifying the Social Phenotype in Autism
Ami Klin, Ph.D.; Warren Jones, B.A.; Robert Schultz, Ph.D.; Fred Volkmar, M.D.; Donald Cohen, M.D.
Contact With Mental Health and Primary Care Providers Before Suicide: A Review of the Evidence
Jason B. Luoma, M.A.; Catherine E. Martin, M.A.; Jane L. Pearson, Ph.D.
Two-Year Prospective Follow-Up of Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype
Barbara Geller, M.D.; James L. Craney, M.S., M.P.H.; Kristine Bolhofner, B.S.; Michael J. Nickelsburg, Ph.D.; Marlene Williams, R.N.; Betsy Zimerman, M.A.
Regional Patterns of Brain Activity in Adults With a History of Childhood-Onset Depression: Gender Differences and Clinical Variability
Anita Miller, Ph.D.; Nathan A. Fox, Ph.D.; Jeffrey F. Cohn, Ph.D.; Erika E. Forbes, M.S.; Joel T. Sherrill, Ph.D.; Maria Kovacs, Ph.D.
Predicting Posttraumatic Distress in Hospitalized Trauma Survivors With Acute Injuries
Douglas F. Zatzick, M.D.; Sun-Mee Kang, Ph.D.; Hans-Georg Müller, M.D., Ph.D.; Joan E. Russo, Ph.D.; Frederick P. Rivara, M.D., M.P.H.; Wayne Katon, M.D.; Gregory J. Jurkovich, M.D.; Peter Roy-Byrne, M.D.
Smoking and Depression: An Examination of Mechanisms of Comorbidity
Lisa C. Dierker, Ph.D.; Shelli Avenevoli, Ph.D.; Marilyn Stolar, M.A.; K.R. Merikangas, Ph.D.
Activation in Mesolimbic and Visuospatial Neural Circuits Elicited by Smoking Cues: Evidence From Functional Magnetic Resonance Imaging
Deborah L. Due, Ph.D.; Scott A. Huettel, Ph.D.; Warren G. Hall, Ph.D.; David C. Rubin, Ph.D.
Effect of Impaired Recognition and Expression of Emotions on Frontocingulate Cortices: An fMRI Study of Men With Alexithymia
Sylvie Berthoz, Ph.D.; Eric Artiges, M.D., Ph.D.; Pierre-François Van de Moortele, M.D., Ph.D.; Jean-Baptiste Poline, Ph.D.; Stéphanie Rouquette, Ph.D.; Silla M. Consoli, M.D.; Jean-Luc Martinot, M.D., Ph.D.
Syndromes and Phenomenological Subtypes Underlying Acute Mania: A Factor Analytic Study of 576 Manic Patients
Tetsuya Sato, M.D., Ph.D.; Ronald Bottlender, M.D.; Nikolaus Kleindienst, M.S.; Hans-Jürgen Möller, M.D.
Deficits in Sustained Attention in Schizophrenia and Affective Disorders: Stable Versus State-Dependent Markers
Shi K. Liu, M.D.; Chia-Hui Chiu, M.S.; Ching-Jui Chang, M.D.; Tzung-Jeng Hwang, M.D.; Hai-Gwo Hwu, M.D.; Wei J. Chen, M.D., Sc.D.
Historical, Psychopathological, Neurological, and Neuropsychological Aspects of Deficit Schizophrenia: A Multicenter Study
Silvana Galderisi, M.D., Ph.D.; Mario Maj, M.D., Ph.D.; Armida Mucci, M.D., Ph.D.; Giovanni Battista Cassano, M.D.; Giordano Invernizzi, M.D.; Alessandro Rossi, M.D.; Antonio Vita, M.D.; Liliana Dell’Osso, M.D.; Enrico Daneluzzo, M.D.; Stefano Pini, M.D., Ph.D.
The General Fertility Rate in Women With Psychotic Disorders
Louise Michele Howard, M.Sc., M.R.C.Psych., M.R.C.P.; Channi Kumar, Ph.D., F.R.C.Psych.; Morven Leese, Ph.D.; Graham Thornicroft, Ph.D., F.R.C.Psych.
Multiple Idiopathic Physical Symptoms in the ECA Study:Competing-Risks Analysis of 1-Year Incidence, Mortality, and Resolution
Charles C. Engel, Jr., M.D., M.P.H.; Xian Liu, Ph.D.; Charles Hoge, M.D.; Samantha Smith, Ph.D.
Trends in the Treatment of Bipolar Disorder by Outpatient Psychiatrists
Carlos Blanco, M.D., Ph.D.; Gonzalo Laje, M.D.; Mark Olfson, M.D., M.P.H.; Steven C. Marcus, Ph.D.; Harold Alan Pincus, M.D.
Olanzapine Versus Divalproex in the Treatment of Acute Mania
Mauricio Tohen, M.D., Dr.P.H.; Robert W. Baker, M.D.; Lori L. Altshuler, M.D.; Carlos A. Zarate, M.D.; Trisha Suppes, M.D., Ph.D.; Terrence A. Ketter, M.D.; Denai R. Milton, M.S.; Richard Risser, M.S.; Julie A. Gilmore, Ph.D.; Alan Breier, M.D.; Gary A. Tollefson, M.D., Ph.D.
Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder
Robert M. Bilder, Ph.D.; Robert S. Goldman, Ph.D.; Jan Volavka, M.D, Ph.D.; Pal Czobor, Ph.D.; Matthew Hoptman, Ph.D.; Brian Sheitman, M.D.; Jean-Pierre Lindenmayer, M.D.; Leslie Citrome, M.D., M.P.H.; Joseph McEvoy, M.D.; Michal Kunz, M.D.; Miranda Chakos, M.D.; Thomas B. Cooper, M.A.; Terri L. Horowitz, Ph.D.; Jeffrey A. Lieberman, M.D.
Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in Schizophrenia
Norbert Müller, M.D., Ph.D.; Michael Riedel, M.D.; Constanze Scheppach; Bernd Brandstätter, M.D.; Safet Sokullu, M.D.; Karin Krampe, M.D.; Markus Ulmschneider; Rolf R. Engel, Ph.D.; Hans-Jürgen Möller, M.D.; Markus J. Schwarz, M.D.
Relationship of the Use of Adjunctive Pharmacological Agents to Symptoms and Level of Function in Schizophrenia
Robert W. Buchanan, M.D.; Julie Kreyenbuhl, Pharm.D., Ph.D.; Julie M. Zito, Ph.D.; Anthony Lehman, M.D., M.P.H.
Attention Deficit Hyperactivity Disorder and the Gene for Dopamine Beta-Hydroxylase
Karen Wigg, B.Sc.; Gwyneth Zai, B.Sc.; Russell Schachar, M.D.; Rosemary Tannock, Ph.D.; Wendy Roberts, M.D.; Molly Malone, Ph.D.; James L. Kennedy, M.D.; Cathy L. Barr, Ph.D.
Long-Term Menstrual and Reproductive Function in Patients With Bulimia Nervosa
Scott J. Crow, M.D.; Paul Thuras, Ph.D.; Pamela K. Keel, Ph.D.; James E. Mitchell, M.D.
Higher Levels of CSF Homovanillic Acid in Recently Abstinent Cocaine-Dependent Patients
Alec Roy, M.D.; Jeffrey Berman, M.D.; Redford Williams, M.D.; Cynthia Kuhn, Ph.D.; Bienvenido Gonzalez, P.A.
Weight Gain Associated With Increased Food Intake and Low Habitual Activity Levels in Male Adolescent Schizophrenic Inpatients Treated With Olanzapine
Doron Gothelf, M.D.; Bareket Falk, Ph.D.; Pierre Singer, M.D.; Michal Kairi, M.Sc.; Moshe Phillip, M.D.; Levana Zigel, M.Sc.; Irit Poraz, Ph.D.; Siegal Frishman, B.A.; Naama Constantini, Ph.D.; Gil Zalsman, M.D.; Abraham Weizman, M.D.; Alan Apter, M.D.
Olanzapine-Induced Weight Gain in Patients With First-Episode Schizophrenia: A Double-Blind, Placebo-Controlled Study of Fluoxetine Addition
Michael Poyurovsky, M.D.; Artashes Pashinian, M.D.; Irit Gil-Ad, Ph.D.; Rachel Maayan, Ph.D.; Michael Schneidman, M.D.; Camil Fuchs, Ph.D.; Abraham Weizman, M.D.
Overdose of Ziprasidone
MATT HOUSE, D.O.
Quetiapine for Olanzapine-Induced Galactorrhea
STEVEN J. KINGSBURY, M.D., PH.D.; CATHERINE CASTELO, M.D.; OSAMA ABULSEOUD, M.D.
Prolongation of QTc Interval and Antipsychotics
KUAN-PIN SU, M.D.; HUI-CHIH CHANG, M.S.; WINSTON W. SHEN, M.D.
Prolongation of QTc Interval and Antipsychotics
DAVID M. TAYLOR, B.SC., M.SC., M.R.PHARM.S.
Drs. Glassman and Bigger Reply
ALEXANDER H. GLASSMAN, M.D.; J. THOMAS BIGGER, JR., M.D.
Regional Selectivity in Clozapine Treatment?
ROBERT M. KESSLER, M.D.; HERBERT Y. MELTZER, M.D.
Diseases of the Mind and Brain: Overview
Carol A. Tamminga, M.D.; Deborah R. Medoff, Ph.D.; Arnold M. Cooper, M.D.
Ernst Grünthal, 1894–1972
Peter Kalus, M.D.; Thomas J. Müller, M.D.; Werner K. Strik, M.D.